Background and objectives. Patients with rheumatoid arthritis (RA) frequently suffer from muscle weakness. Oral administration of creatine has been shown to improve muscle strength in healthy subjects. The objective of this study was to examine the effect of oral creatine supplementation on muscle weakness, disease activity and activities of daily living in patients with RA.
The importance of muscle weakness in the disability of activity has been found to be associated with muscle weakness, suggesting that alterations in creatine metapatients with rheumatoid arthritis (RA) has long been bolism may be involved [9] . Similar to patients with recognized [1] [2] [3] [4] [5] . Muscle weakness is generally attrib-RA, patients with gyrate atrophy also have type 2 uted to a reflex response to pain, joint deformation or muscle fibre atrophy [10] . In this group of patients, this disuse, extra-articular manifestations of the disease change in muscle fibre composition is associated with a and/or psychological factors. In comparison, muscle decrease in the skeletal muscle creatine content which inflammation with an increase in serum creatine kinase can be corrected by the administration of creatine. (CK ) activity and specific histological changes are rare
In healthy persons and patients with chronic heart in patients with RA [6, 7] .
failure, oral administration of high doses of creatine More commonly, muscle weakness in RA is accomincreased the skeletal muscle creatine and phosphocreatpanied by normal or low serum CK activity, lack of ine content in most but not all subjects [11] [12] [13] [14] [15] [16] . This abnormalities in electromyographic examination and increase was generally associated with an increase in non-specific type 2 fibre atrophy [7, 8] . Low serum CK short-term exercise capacity [13, [15] [16] [17] [18] , but had no beneficial effect on aerobic exercise capacity [19, 20] . On the basis of these studies, we hypothesized that the administration of creatine may improve the skeletal muscle function of patients with RA. We therefore DAS, only 28 and not 68 joints are examined, reducing the burden for the patients without being less accurate investigated the effects of long-term oral administration of creatine on physical performance and skeletal muscle [25] . Creatine in serum, urine and skeletal muscle was creatine metabolism of patients with RA.
determined spectrophotometrically according to Bernt et al. [26 ] . Creatine phosphate in skeletal muscle Materials and methods was determined spectrophotometrically according to Lamprecht et al. [27] . The coefficient of variation of the Design technique that was used to measure the muscle creatine The study was a 3-week open study of creatine and muscle creatine phosphate levels is below 5%. The supplementation in 12 RA patients fulfilling the muscle creatine content is expressed per g tissue wet American College of Rheumatology (ACR) criteria for weight. Laboratory assessment also included the ESR RA [21] . It was reviewed and accepted by the Ethics and serum CK activity which were determined by routine Committee of the Medical Faculty of the University methods of clinical chemistry. of Zurich.
Analyses and sample size Intervention
The differences between the values before and after A 3-week supplementation with creatine monohydrate treatment were tested by a one-sample t-test. The level chewing tablets ( Wander Pharma, Bern, Switzerland ) of significance was set to 0.05. The sample size calculawas given. We administered 20 g/day (four times 5 g) tion was based on a one-sided paired t-test (pre-and for the first 5 days ( loading phase) and 2 g/day (four post-medication strength constitute the matched pairs). times 0.5 g) for the remaining 16 days (maintenance We calculated that 11 pairs of before and after measurephase). This dosage was based on creatine supplements would be needed to detect an improvement of at mentation in clinical [13] and experimental studies [11, least 20% (the assumed minimal difference of clinical 12, 14] , in which no side-effects associated with this importance) with a power of 90% given that such a intervention were reported. According to the protocol, difference actually exists. patients were asked not to change their habits and
The primary outcome variable tested was the MSI. physical activity during the study.
To examine whether the expected increase in isometric Data collection muscle strength would translate into statistically significant and clinically meaningful gains in physical funcAll participants were examined on entry and at the end tional ability, we also examined for changes in the HAQ of the study. These investigations included the collection score. Unless stated otherwise, data are presented as of a blood sample and 24-h urine, a clinical examination, mean ± .. a muscle biopsy (quadriceps) and muscle strength measurements (elbow and knee). In addition, the participants had to complete self-administered questionnaires.
Results

Measures
Patients While isokinetic measurements have been used in studies
We obtained full clinical and questionnaire data from by Greenhaff et al. [17] , this type of exercise caused all patients. However, skeletal muscle biopsy was pospain to patients with RA in pre-testing. We thus used sible in 12 patients at the start of the study but in only isometric muscle strength measurements in the form of nine patients at the end (three patients refused a second a muscle strength index (MSI ) which has been validated biopsy). The mean age of the study population was in patients with RA. The MSI includes measurements 54 yr (.. = 13), with a range of 28-70 yr. Seventy-five of knee and elbow extension and flexion. To reduce the per cent of patients were female. The mean weight was burden of measurements we restricted the measurements 68 kg (.. = 4) and the mean height was 166 cm to the left side of the body (the resulting index is of (.. = 3). The medium duration of disease was 9 yr virtually identical reliability as compared with the test (range 1-26 yr). The rheumatoid factor was positive in assessing both sides) [5] .
11 of 12 patients. To examine physical functional disability we used the Side-effects and compliance Health Assessment Questionnaire (HAQ) [22, 23] , one of the most frequently used instruments for measuring During the study period, patients reported no adverse functional disability and daily activities in patients with events associated with the ingestion of creatine. All RA. The HAQ measures the capabilities in dressing, patients maintained creatine supplementation during the arising, walking, hygiene, reaching, gripping, and other whole study period, as assessed by tablet counting and activities. The questionnaire is self-administered and determination of creatine concentrations in serum and takes less than 5 min to complete.
urine (see below). To control for disease activity we used the disease Muscle strength and physical functional ability activity score (DAS) which is calculated based on the number of swollen and tender joint counts and the Muscle strength as measured by the MSI showed an increase in eight of 12 patients and reached statistical erythrocyte sedimentation rate ( ESR) [24] . For the Creatine metabolism As shown in Table 1 and Fig. 2 , the skeletal muscle creatine content increased in eight of the nine patients studied with creatine administration (P = 0.04). In contrast, the skeletal muscle content of creatine phosphate as well as the total creatine content did not change significantly. The serum creatine concentration and the urinary excretion of creatine increased by a factor of 4 and 30, respectively, with creatine supplementation, suggesting that the patients were compliant. Urinary excretion of creatine at the end of the study was 2 g/day, accounting for 100% of the dose ingested. The serum activity of CK did not change with creatine administration.
Association between creatine metabolism and muscle strength
Cross-sectionally, the skeletal muscle creatine content was associated with the MSI at baseline (r = 0.55, P = 0.06), but not after treatment with creatine (r = 0.03). Instead, neither the phosphocreatine nor the total creatine content were associated with the MSI at both time points. Longitudinally, the changes in the MSI following creatine administration were not associated with any of the creatine parameters. Interestingly, the patients showed a concomitant increase in muscle strength.
significance ( Table 1 and Our study illustrates that patients with RA can be treated safely with high doses of creatine. Regarding all and for the flexion of elbow and knee, but was not significant for the extension of elbow and knee patients as one group, this treatment is associated with an increase in muscle strength but not in the skeletal (P = 0.08). The MSI was associated with physical functional ability as measured with the HAQ both at baseline muscle creatine content. The skeletal muscle creatine content in the patients (r = −0.71, P = 0.01) and after treatment with creatine (r = −0.62, P = 0.03). However, physical functional studied was 23 mmol/g wet weight, which corresponds to approximately 115 mmol/g dry weight, assuming a disability (HOQ) did not change significantly with the administration of creatine, whereas disease activity as water content of 80% [28] . This value agrees well with the 110-140 mmol/g dry weight reported in studies with measured with the DAS showed a significant decrease. F. 2. Creatine content in skeletal muscle before and after treatment with creatine. The creatine content increased in eight of nine patients with treatment ( left), whereas the total creatine content (creatine and phosphocreatine) showed no significant change (right).
normal subjects [11] [12] [13] [14] , suggesting that the skeletal Creatine supplementation has been shown to be associated with increased muscle strength during short-term muscle creatine metabolism is not disturbed profoundly in patients with RA. Treatment with creatine led to an exercise in normal subjects [15] [16] [17] [18] and in patients with chronic heart disease [13] . On the other hand, no effect increase in the skeletal muscle creatine content in eight of the nine patients, whereas creatine phosphate and the of creatine supplementation could be demonstrated in normal subjects performing long-term exercise [19, 20] . total creatine content did not change significantly. In normal subjects, similar treatments were associated with These findings are in agreement with the physiological role of the creatine/creatine phosphate system, which a 10-20% increase in the total skeletal muscle creatine content in most [11, [13] [14] [15] but not all subjects studied provides energy for less than a minute in a maximally working skeletal muscle [29] . The MSI used in the [12] . Since poor compliance and technical problems in the quantification of creatine are unlikely to be the current studies is calculated from the maximal force achieved by different muscle groups during isometric reasons for our findings, the exact causes for the lack of increase in the skeletal muscle creatine content in contraction over a short time. This type of muscle contraction corresponds to short-term exercise and patients with RA remain unclear. As indicated by the urinary excretion of creatine, which equalled the dose could therefore potentially be affected by the skeletal muscle creatine content. Indeed, administration of creatadministered, reduced absorption of creatine can be excluded. The most probable reasons for our findings ine was associated with an increase in the MSI in eight of 12 patients, reaching statistical significance. This include, therefore, alterations in the kinetics of creatine in patients with RA, for instance altered distribution increase cannot be explained by changes in the skeletal muscle creatine content, however, since there was no (e.g. reduced transport into skeletal muscle), increased metabolism and/or increased excretion. Since our study association between these two variables and the skeletal muscle total creatine content did not increase. On the was not designed to answer these questions, further studies are necessary to investigate in more detail creatother hand, there was a significant association between the skeletal muscle total creatine content and muscle ine metabolism in patients with RA.
